(Q46202394)

20 December 2017

title

Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study (English)

1 reference

20 December 2017

1 reference

1

1 reference

20 December 2017

author name string

T Ramey

2

1 reference

20 December 2017

D Keller

3

1 reference

20 December 2017

P A English

4

1 reference

20 December 2017

A D Loebel

5

1 reference

20 December 2017

J Miceli

6

1 reference

20 December 2017

language of work or name

English

0 references

publication date

12 December 2008

1 reference

20 December 2017

Journal of Psychopharmacology

published in

1 reference

20 December 2017

volume

24

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

547-558

1 reference

20 December 2017

Is there a role for 5-HT1A agonists in the treatment of depression?

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Treatment of acute mania--from clinical trials to recommendations for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Molecular targets in the treatment of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

What really matters to bipolar patients' caregivers: sources of family burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

Atypical antipsychotics in the treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108099418

21 January 2018

Identifiers

DOI

10.1177/0269881108099418

1 reference

20 December 2017

1 reference

20 December 2017